The formulation of each medicine – just like the molecule assigned to each Therapeutic disease – is unique. Sushen initiates each of its medicine development projects with a comprehensive development plan.
The strategy for developing medicines is based on the thorough analysis of pre-formulatory data.
In certain cases, development poses significant challenges, for example, if the active ingredient's bio-availabillity is low, its water-solubility and/or permeability is poor, or its physiological stability is poor. The development of the pharmaceutical form during the process helps to overcome these problems.